Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
PRLD Prelude Therapeutics
- 0.685
- +0.015+2.25%
Trading Mar 11 10:21 ET
37.79MMarket Cap-0.41P/E (TTM)
0.849High0.670Low41.77KVolume0.673Open0.670Pre Close32.20KTurnover0.24%Turnover RatioLossP/E (Static)55.15MShares6.80052wk High0.29P/B12.18MFloat Cap0.67052wk Low--Dividend TTM17.78MShs Float95.375Historical High--Div YieldTTM26.69%Amplitude0.670Historical Low0.771Avg Price1Lot Size
About Prelude Therapeutics Company
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Company Profile
SymbolPRLD
Company NamePrelude Therapeutics
Listing DateSep 25, 2020
Issue Price19.00
Founded2016
CEODr. Krishna Vaddi, PhD
MarketNASDAQ
Employees131
Fiscal Year Ends12-31
Address175 Innovation Boulevard
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19805
Phone1-302-467-1280
Websitehttp://www.preludetx.com
Company Executives
- Name
- Position
- Salary
- Dr. Krishna Vaddi, PhD
- Director and Chief Executive Officer
- 2.64M
- Peggy A. Scherle, PhD
- Chief Scientific Officer
- --
- Andrew P. Combs, PhD
- Chief Chemistry Officer
- --
- Bryant D. Lim
- Chief Financial Officer, Chief Legal Officer and Corporate Secretary
- 1.61M
- Dr. Jane Huang, M.D.
- President and Chief Medical Officer
- 1.65M
- Dr. Paul A. Friedman,M.D.
- Chairman of the Board
- 161.03K
- Mardi C. Dier
- Independent Director
- 147.03K
- Martin Babler
- Independent Director
- 134.53K
- Julian C. Baker
- Independent Director
- 140.03K
- Dr. David P. Bonita, M.D.
- Independent Director
- 144.53K
- Dr. Victor Sandor, C.M.,M.D.
- Independent Director
- 131.03K